CSF1R and inflammatory bowel disease: demonstrated CEBPB’s key role in monocyte/macrophage regulation, potentially affecting IBD immune responses by upregulating Csf1r expression (38), indicating CEBPB’s core function in IBD pathology and its potential as a therapeutic target.